TRexBio Alternatives & Competitors
12 companies similar to TRexBio — Decoding Human Tissue Biology to Create Revolutionary Therapeutics
Odyssey Therapeutics
Building a machine learning-based platform to develop novel therapeutics focusing on cance...
Barinthus Biotherapeutics
Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunother...
Oxford, United Kingdom
Noa Therapeutics
Noa Therapeutics is transforming the treatment of inflammatory barrier diseases.
Toronto, Canada
ImageneBio
San Diego, United States
Track all TRexBio competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Oxford, United Kingdom
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Cabaletta Bio
Engineered T cell therapies designed for the treatment of patients with autoimmune disease...
Philadelphia, United Stat...
Vial
Vial is a next-gen pharma company advancing best-in-class biologics and RNA therapeutics a...
San Francisco, United Sta...
Sudo Biosciences
Developing precision TYK2 therapeutics.
Carmel, United States
Immune-Onc Therapeutics
Science at Our Core. Patients in Our Hearts.
Palo Alto, United States
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Calluna Pharma
Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis a...
Oslo, Norway
About TRexBio
Decoding Human Tissue Biology to Create Revolutionary Therapeutics
Development of biologics targeting immune balance, Decoding regulatory T cell behavior in human tissue, Creation of tissue-specific therapeutics
Patients with autoimmune diseases, Patients with inflammatory conditions, Healthcare providers in dermatology and gastroenterology
Clinical-stage, Immunoregulatory Medicines, Tissue Biology, Computational Biology, Human Tissue Focus, Immunobiology Expertise, Treg Behavior Mapping, Novel Targets Identification, Therapeutic Intervention, TNFR2-selective Agonist, Effector Tregs Activation, Inflammatory Diseases, Atopic Dermatitis, Immune Homeostasis Restoration
B2B, B2D
Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches TRexBio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at TRexBio on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.